Evidence map›Paper›PMID 36829198›Full record

ArticleBMC women's health2023

Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery.

Mingjun Tang, Wenhui Yang, Haiyan Zhang

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 5 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Progestagens for pain symptoms associated with endometriosis.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mingjun Tang *Department of Gynaecology and Obstetrics, Baotou Central Hospital of Baotou Medical College, No. 61, Huancheng Road, Donghe District, Baotou, 014000, Inner Mongolia Autonomous Region, China.
Wenhui Yang *Department of Gynaecology and Obstetrics, Baotou Central Hospital of Baotou Medical College, No. 61, Huancheng Road, Donghe District, Baotou, 014000, Inner Mongolia Autonomous Region, China.
Haiyan ZhangDepartment of Gynaecology and Obstetrics, Baotou Central Hospital of Baotou Medical College, No. 61, Huancheng Road, Donghe District, Baotou, 014000, Inner Mongolia Autonomous Region, China. zhanghyan0086@126.com.
Baotou Medical College · CNBaotou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the efficacy of dienogest and GnRH-a after endometriosis surgery.

methodsPatients with endometriosis who were admitted to our hospital from December 2020 to March 2022 were randomly collected. A total of 81 patients were collected and divided into 40 cases in the control group and 41 cases in the observation group. Among them, the control group was treated with GnRH-a drug, and the observation group was treated with dienogest (DNG).

resultsThe study found that the therapeutic effects of the two drugs were basically the same in patients with endometriosis. The VAS and Kupperman scores of the control group were 0.78 ± 0.8, 3.9 ± 1.84, P < 0.05, respectively; the VAS and Kupperman scores of the observation group were 0.73 ± 0.78, 1.55, respectively ± 1.24, P < 0.05, the difference was statistically significant.In the case of postoperative recurrence, the observation group was better than the control group, with 8 cases of recurrence in the control group and 2 cases of recurrence in the observation group, P < 0.05.

conclusionIn the comparison of postoperative efficacy of the two drugs on patients with endometriosis, dienogest is better than GnRH-a adjuvant drug in postoperative recurrence, and has a good improvement and application, which is worthy of further promotion in clinical practice.

Indexed as

EndometriosisNandroloneFemaleGonadotropin-Releasing HormoneHormone AntagonistsHumansdienogestGonadotropin-Releasing HormoneHormone AntagonistsNandroloneDienogestEndometriosisVAS score

Identifiers

PMID36829198
PMCPMC9960682
OpenAlexW4321782573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.